Detalhe da pesquisa
1.
Novel immunotherapy for malignant melanoma with a monoclonal antibody that blocks CEACAM1 homophilic interactions.
Mol Cancer Ther
; 11(6): 1300-10, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22466331